Filters

CCNYL2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

CCNYL2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) size: 1.0 µg DNA 600

Supplier ABM LENTIVECTORS
Price 600
Size 1.0 µg DNA
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
DNA lentivector for transduction information GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene targetCCNYL2 Lentiviral Vector (EF1a) (pLenti-GIII-EF1a)
Short nameCCNYL2 Lentiviral Vector ( ) (EF1a) (pLenti-GIII-EF1a)
TechniqueVectors
Species Humans, Human
Alternative name sapiens) (EF1a) (pLenti-GIII-EF1a), CCNYL2 Lentiviral integrating Desoxyribonucleic acid sequence (H
Identity 23495
Gene CCNYL2
Long gene name cyclin Y-like 2 (pseudogene)
Synonyms gene C10orf21
Synonyms gene name chromosome 10 open reading frame 21 cyclin Y-like 2
Synonyms bA178A10, 2 CCNYL2P
Locus 10q11, 21
Discovery year 2004-05-27
GenBank acession BC039000
Entrez gene record 414194
RefSeq identity XM_936368
Classification Cyclins
Havana BLAST/BLAT OTTHUMG00000018009

Similar products

Subscribe to our Newsletter